-transparent.png){kind=logo}
Carnitine palmitoyltransferase II (CPT II) deficiency is an autosomal recessive disorder of mitochondrial fatty-acid oxidation which presents as three distinct phenotypes (neonatal, infantile, and adult onset). CPT II exons from an adult-onset CPT II-deficient patient were amplified and directly sequenced to further investigate the molecular basis of this disorder. A novel mutation, C471T, in exon 4 of the carnitine palmitoyltransferase II gene was found which created a stop codon, TGA, at residue 124 of the protein (R124Stop). This mutation would result in severe protein truncation. This unique mutation was found on one allele while the S113L mutation, previously reported, was present on the other allele.
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
February 2002,
Molecular genetics and metabolism,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
June 2022,
Cureus,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
June 2003,
Molecular genetics and metabolism,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
April 2002,
Nihon rinsho. Japanese journal of clinical medicine,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
March 2021,
Ideggyogyaszati szemle,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
January 1999,
Human mutation,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
January 1994,
The Journal of pediatrics,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
January 1998,
Ryoikibetsu shokogun shirizu,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
January 2001,
Ryoikibetsu shokogun shirizu,
B Z Yang, and
J H Ding, and
D Roe, and
T Dewese, and
D W Day, and
C R Roe
January 2003,
Journal of inherited metabolic disease,
